Skip to main content
Log in

Phenetic comparison of sevenEchinacea species based on immunomodulatory characteristics

  • Published:
Economic Botany Aims and scope Submit manuscript

Abstract

The purpose of the present investigation was to compare similarities and differences in immune response among Echinacea species, which are commonly used to treat upper respiratory infections. The investigation involved two components: acquisition of immunomodulatory data reported here for the first time, and combined phenetic analysis of these data along with previous reports. Experimental data were obtained by stimulating human PBMC in vitro with extracts from Echinacea spp. and assaying production of three cytokines (interleukin-1β [IL-1β] interleukin-2 [IL-2], and tumor necrosis factor α [TNF-α]). Phenetic analyses were employed to compare responses across the entire data set, including UPGMA (Unweighted Pair Group Method with Arithmetic Mean) and neighbor-joining methods. In the immune experiments conducted for this investigation, E. angustifolia,E. paradoxa, E. purpurea, E. simulata, andE. tennesseensis extracts significantly augmented IL-1 β and TNF-α production, whereas no extracts significantly modulated IL-2. All phenetic methods produced similar dendrograms, revealing two species pairs (E. angustifolia + E. simulata and E. pallida + E.sanguinea) where both species cluster tightly and have similar immune-response profiles. These two species-pairs are maximally dissimilar from each other. The remaining species (E. paradoxa, E. purpurea, and E. tennesseensis) occupy intermediate positions in the dendrogram. Our results suggest that Echinacea spp. act heterogeneously on immune function. The utility of these data for science and industry is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  • Barak V., S. Birkenfeld, T. Halperin, I. Kalickman. 2002. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Israel Medical Association Journal 4:919–922.

    PubMed  Google Scholar 

  • Barnes, J., Anderson L. A., S. Gibbons, J.D. Phillipson. 2005.Echinacea species (Echinacea angustifolia (DC.) Hell.,Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): A review of their chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology 57:929–954.

    Article  PubMed  CAS  Google Scholar 

  • Barrett, B.P., R.L. Brown, K. Locken, R. Maberry, J.A. Bobula, D. D’Alessio. 2002. Treatment of the common cold with unrefinedEchinacea. Annals of Internal Medicine 137:939–946.

    PubMed  Google Scholar 

  • Binns, S.E., B.R. Baum, and J.T. Arnason. 2002a. A taxonomic revision ofEchinacea (Asteraceae: Heliantheae). Systematic Botany 27:610–632.

    Google Scholar 

  • —, J. Hudson, S. Merali, J.T. Arnason. 2002b. Antiviral activity of characterized extracts fromEchinacea spp. (Heliantheae: Asteraceae) againstHerpes simplex virus (HSV-I). Planta Medica 68:780–783.

    Article  PubMed  CAS  Google Scholar 

  • Bodinet, C., U. Lindequist, E. Teuscher, J. Freudenstein. 2002. Effect of an orally applied herbal immunomodulator on cytokine induction and antibody response in normal and immunosuppressed mice. Phytomedicine 9:606–613.

    Article  PubMed  CAS  Google Scholar 

  • Caruso, T. J. and J.M. Gwaltney. 2005. Treatment of the common cold withEchinacea: A structured review. Clinical Infectious Diseases 40:807–810.

    Article  PubMed  Google Scholar 

  • Cundell, D.R., M.A. Matrone, P. Ratajczak, J.D. Pierce, Jr. 2003. The effect of aerial parts ofEchinacea on the circulating white cell levels and selected immune functions of the aging male Sprague-Dawley rat. International Immunopharmacology 3:1041–1048.

    Article  PubMed  CAS  Google Scholar 

  • Durum, S.K., J.A. Schmidt, J.J. Oppenheim. 1985. Interleukin-1: An immunological perspective. Annual Review of Immunology 3:263–287.

    Article  PubMed  CAS  Google Scholar 

  • Elsasser-Beile, U., W. Willenbacher, H.H. Bartsch, H. Gallati, J. Sculte Monting, S. van Kleist. 1996. Cytokine production in leukocyte cultures during therapy withEchinacea extract. Journal of Clinical Laboratory Analysis 10:441–445.

    Article  PubMed  CAS  Google Scholar 

  • Gertsch, J., R. Schoop, U. Kuenzle, A. Sutter. 2004.Echinacea alkylamides modulate TNF-> gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Letters 577:563–569.

    Article  PubMed  CAS  Google Scholar 

  • Goel, V., R. Lovlin, C. Chang, J. V. Slama, R. Barton, R. Gahler, R. Bauer, L. Goonewardene, T.K. Basu. 2005. A proprietary extract from the echinacea plant (Echinacea purpurea) enhanced systemic immune response during a common cold. Phytotherapy Research 19:689–694.

    Article  PubMed  Google Scholar 

  • Kohut, M.L. and D.S. Senchina. 2004. Reversing age-associated immunosenescence via exercise. Exercise Immunology Review 10:6–41.

    PubMed  Google Scholar 

  • Lindenmuth, G.F. and E.B. Lindenmuth. 2000. The efficacy ofEchinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: A randomized, double-blind placebo-controlled study. Journal of Alternative and Complementary Medicine 6:327–334.

    Article  CAS  Google Scholar 

  • Luettig, B., C. Steinmuller, G.E. Gifford, H. Wagner, M.L. Lohmann-Matthes. 1989. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures ofEchinacea purpurea. Journal of the National Cancer Institute 81:669–675.

    Article  PubMed  CAS  Google Scholar 

  • McCann, D. A., F. Macaluso, M. L. Kohut, D. S. Senchina. n.d. Cytokine- and interferon-modulating properties of Echinacea spp. root tinctures stored at -20 degrees C for 2 years. Submitted.

  • McGregor, R. L. 1968. The taxonomy of the genusEchinacea (Compositae). The University of Kansas Science Bulletin 48:113–142.

    Google Scholar 

  • Randolph, R.K., K. Gellenbeck, K. Stonebrook, E. Brovelli, D. Bankaitis-Davis, J. Cheronis. 2003. Regulation of human immune gene expression as influenced by a commercial blendedEchinacea product: Preliminary studies. Experimental Biology and Medicine 228:1051–1056.

    PubMed  CAS  Google Scholar 

  • Rininger, J., S. Kickner, P. Chigurupati, A. McLean, Z. Franck. 2000. Immunopharmacological activity ofEchinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. Journal of Leukocyte Biology 68:503–510.

    PubMed  CAS  Google Scholar 

  • Schulten, B., M. Bulitta, B. Ballering-Bruhl, U. Koster, M. Schafer. 2001. Efficacy ofEchinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial. Arzneimittelforschung 51:563–568.

    PubMed  CAS  Google Scholar 

  • Schwarz, E., J. Metzler, J. P. Diedrich, J. Freuden-Stein, C. Bode, J. C. Bode. 2002. Oral administration of freshly expressed juice ofEchinacea purpurea herbs fail to stimulate the nonspecific immune response in healthy young men: Results of a double-blind, placebo-controlled crossover study. Journal of Immunotherapy 25:413–420.

    Article  PubMed  Google Scholar 

  • Senchina, D.S., L. Wu, G.N. Flinn, D.N. Konopka, J.A. McCoy, M.P. Widrlechner, E.S. Wurtele, M. L. Kohut. n.d. Year-and-a-half old, driedEchinacea spp. roots retain cytokine-modulating capa-bilities in an in vitro human older adult model of influenza vaccination. Submitted.

  • —, D. A. McCann, J. M. Asp, J. A. Johnson, J. E. Cunnick, M.S. Kaiser, M.L. Kohut. 2005. Changes in immunomodulatory properties ofEchinacea spp. root infusions and tinctures stored at 4°C for four days. Clinica Chimica Acta 355:67–82.

    Article  CAS  Google Scholar 

  • Smith, K.A. 1984. Interleukin 2. Annual Review of Immunology 2:319–333.

    Article  PubMed  CAS  Google Scholar 

  • Stimpel, M., A. Proksch, H. Wagner, M. L. Lohmann-Matthes. 1984. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plantEchinacea purpurea. Infection and Immunity 46:845–849.

    PubMed  CAS  Google Scholar 

  • Strieter, R.M., S.L. Kunkel, and R.C. Bone. 1993. Role of tumor necrosis factor-alpha in disease states and inflammation. Critical Care Medicine 21:S447-S463.

    Article  PubMed  CAS  Google Scholar 

  • Swofford, D.L. 2003. PAUP*. Phenetic Analysis Using Parsimony (*and other methods). Version 4.0bl0. Sunderland, Massachusetts: Sinaeur Associates.

    Google Scholar 

  • Team, R.D.C. 2005. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.

    Google Scholar 

  • Turner, R.B., R. Bauer, K. Woelkart, T.C. Hulsey, J. D. Gangemi. 2005. An evaluation ofEchinacea angustifolia in experimental rhinovirus infections. New England Journal of Medicine 353:341–348.

    Article  PubMed  CAS  Google Scholar 

  • Yale, S.H. and K. Liu. 2004.Echinacea purpurea therapy for the treatment of the common cold: A randonmized, double-blind, placebo-controlled clinical trial. Annals of Internal Medicine 164:1237–1241.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marian L. Kohut.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senchina, D.S., Flagel, L.E., Wendel, J.F. et al. Phenetic comparison of sevenEchinacea species based on immunomodulatory characteristics. Econ Bot 60, 205–211 (2006). https://doi.org/10.1663/0013-0001(2006)60[205:PCOSES]2.0.CO;2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1663/0013-0001(2006)60[205:PCOSES]2.0.CO;2

Key Words

Navigation